MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Detection of Cognitive Changes in Premanifest Huntington’s disease Using the Repeatable Battery for the Assessment of Neuropsychological Status

    A. Mustafa, J. Corey-Bloom, H. Smith, J. Castleton, P. Gilbert (San Diego, CA, USA)

    Objective: The current study is an examination of cognitive changes in premanifest gene carriers for Huntington’s disease (preHD), individuals with manifest Huntington’s disease (HD), and…
  • MDS Virtual Congress 2020

    Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease

    P. Bugalho, F. Ladeira, R. Barbosa, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisboa, Portugal)

    Objective: Assess the predicitive value of dream content for cognitive dysfuncion progression in Parkinson's Disease (PD). Background: PD patients frequently complain of vivid dreams. Cross-sectional…
  • MDS Virtual Congress 2020

    Genetic and environmental prognostics of cognitive trajectories in patients with Parkinson’s disease

    S. Jo, K.W Park, S.H Lee, Y.S Hwang, S.J Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the progression patterns of cognitive impairment in patients with Parkinson’s disease (PD), and to identify the baseline predictors, including both…
  • MDS Virtual Congress 2020

    Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)

    J. Montillot, H. Salhi, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, A. Bachoud-Lévi, P. Rémy (Créteil, France)

    Objective: We explored the capacity of a new digitalized multi-domain cognitive battery, to differentiate PD patients with MCI from those without MCI. Background: MCI is…
  • MDS Virtual Congress 2020

    Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

    Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)

    Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…
  • MDS Virtual Congress 2020

    Free Water in Corpus Callosum is Sensitive to Parkinson’s Disease-related Cognitive Decline

    G. Brown, G. Du, M. Lewis, X. Liu, E. Lee, P. Eslinger, L. Kong, J. Hakun, X. Huang (Hershey, PA, USA)

    Objective: The objective of this study was to determine if the novel diffusion metric, free water (FW), from two-tensor modeling could sensitively identify microstructural alterations…
  • MDS Virtual Congress 2020

    Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease

    H. Zheng, D. Huang, C. Xu, Y. sun (Nanjing, China)

    Objective: Due to the high prevalence of mild cognitive impairment (MCI) in Parkinson disease (PD), routine cognitive screening is important for the optimal management of…
  • MDS Virtual Congress 2020

    Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

    C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)

    Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • MDS Virtual Congress 2020

    Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment

    J. Chandler, R. Nair, E. Ferries, L. Munsie, T. Changamire, N. Patel, K. Biglan (Louisville, KY, USA)

    Objective: The primary goal of this retrospective cohort study was to understand characteristics, healthcare resource use (HCRU) and costs of patients with PD before and…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley